Furthermore, the treatment of granulocytes with Gal-9 up-regulated the expression and activity of PAD-4, a key enzyme that citrullinates proteins, which is also increased in bronchial lavage of RA patients [32]. The gene discussed is LGALS9; the disease is rheumatoid arthritis.